Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SciClone Pharmaceuticals Inc.

www.sciclone.com

Latest From SciClone Pharmaceuticals Inc.

Post-IPO Zentalis Plows New Ground With China Oncology Venture

US venture raises new funds from Asia partners as it builds a direct presence in China to develop its oncology portfolio. 

China Business Strategies

Deal Watch: Boehringer, Epizyme Team Up To Develop Epigenetic Cancer Therapies

BI and Epizyme’s collaboration will focus on developing novel cancer drugs targeting helicase and HAT enzyme dysregulation. MorphoSys and I-Mab will partner on developing an IO therapy targeting C5aR.

Deals Business Strategies

Crowdfunding Cancer Drug Development: Ability Pharma Hits Gold

At a time when attracting funding for small companies has become a tricky exercise, Spanish biotech has launched a crowdfunding round which is already proving successful.

Financing Cancer

Biopharma Quarterly Deal-Making Statistics, Q2 2017

Biopharma companies raised $13.4 billion in Q2, mostly through IPOs. Thanks to several billion-dollar deals in Q2, 2017 is shaping up to be a year of CRO consolidations. Big pharma continued divesting assets to smaller biopharma companies.

BioPharmaceutical Deals
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Cardiovascular
  • Immune Disorders
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • SciClone Pharmaceuticals Inc.
  • Senior Management
  • Hong Zhao, CEO, China Ops.
    Lan Xie, VP Finance, CFO China Ops.
    Raymond A Low, VP Finance, Controller
  • Contact Info
  • SciClone Pharmaceuticals Inc.
    Phone: (650) 358-3456
    950 Tower Ln., Ste. 900
    Foster City, CA 94404-2125
    USA
UsernamePublicRestriction

Register